Shining light on Tomorrow

Sanfilippo Syndrome is a rare inherited disorder that affects how the body breaks down certain natural substances called glycosaminoglycans. In children with MPS IIIA, the body is missing an enzyme needed to break down these substances, causing them to build up in the brain and body. Over time, this buildup leads to progressive damage, especially affecting the nervous system.

Children with MPS IIIA often appear to develop typically in early infancy. However, symptoms usually begin to appear in early childhood and may include:

• Delays in speech and learning
• Behavioral challenges, including hyperactivity
• Sleep disturbances
• Gradual loss of previously learned skills

As the condition progresses, it can impact mobility, communication, and overall health.

While there is currently no cure for MPS IIIA, researchers are actively working toward treatments and therapies. Increased awareness and community support play an important role in advancing research and helping affected families feel less alone.

Together, we can make our world a place where every person feels understood, supported, and valued. 💙